361 Capital LLC Purchases Shares of 31,487 Agilent Technologies, Inc. (NYSE:A)

361 Capital LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 31,487 shares of the medical research company’s stock, valued at approximately $2,021,000.

Several other institutional investors also recently made changes to their positions in A. SG Americas Securities LLC boosted its holdings in Agilent Technologies by 37.2% during the 3rd quarter. SG Americas Securities LLC now owns 74,435 shares of the medical research company’s stock valued at $4,779,000 after acquiring an additional 20,185 shares during the period. Timber Hill LLC bought a new stake in Agilent Technologies during the 3rd quarter valued at $1,672,000. Quantbot Technologies LP raised its position in Agilent Technologies by 267.5% during the 3rd quarter. Quantbot Technologies LP now owns 150,421 shares of the medical research company’s stock valued at $9,657,000 after purchasing an additional 109,485 shares in the last quarter. Russell Investments Group Ltd. raised its position in shares of Agilent Technologies by 91.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 371,428 shares of the medical research company’s stock worth $23,847,000 after acquiring an additional 177,891 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Agilent Technologies by 9.9% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock worth $64,086,000 after acquiring an additional 90,317 shares in the last quarter.

Agilent Technologies, Inc. (A) traded down $2.45 during trading hours on Monday, hitting $66.24. The company had a trading volume of 2,899,424 shares, compared to its average volume of 1,862,760. The firm has a market capitalization of $22,106.37, a PE ratio of 28.98, a PEG ratio of 2.08 and a beta of 1.27. Agilent Technologies, Inc. has a 12-month low of $44.11 and a 12-month high of $70.93. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The company had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same period in the prior year, the business posted $0.59 earnings per share. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. sell-side analysts forecast that Agilent Technologies, Inc. will post 2.58 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a $0.149 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.90%. The ex-dividend date is Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.24%.

In related news, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.26, for a total transaction of $326,300.00. Following the transaction, the insider now owns 45,143 shares of the company’s stock, valued at $2,946,032.18. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Jacob Thaysen sold 22,583 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $70.41, for a total value of $1,590,069.03. Following the transaction, the senior vice president now directly owns 63,042 shares in the company, valued at approximately $4,438,787.22. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 151,114 shares of company stock worth $10,359,388.

Several research analysts have recently commented on the company. Deutsche Bank set a $75.00 price target on Agilent Technologies and gave the stock a “buy” rating in a research report on Tuesday, November 21st. J P Morgan Chase & Co boosted their target price on Agilent Technologies to $75.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 21st. Barclays boosted their target price on Agilent Technologies from $67.00 to $71.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 21st. Cowen reiterated a “hold” rating and set a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday, November 22nd. Finally, Robert W. Baird restated a “buy” rating and issued a $72.00 target price on shares of Agilent Technologies in a research note on Friday, November 24th. Six research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $68.34.

TRADEMARK VIOLATION NOTICE: “361 Capital LLC Purchases Shares of 31,487 Agilent Technologies, Inc. (NYSE:A)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/04/361-capital-llc-buys-shares-of-31487-agilent-technologies-inc-a.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply